Senti Biosciences Inc.

3.06
-0.15 (-4.67%)
At close: Apr 03, 2025, 3:59 PM
3.25
6.33%
After-hours: Apr 03, 2025, 07:58 PM EDT

Senti Biosciences Statistics

Share Statistics

Senti Biosciences has 4.83M shares outstanding. The number of shares has increased by -43.21% in one year.

Shares Outstanding 4.83M
Shares Change (YoY) -43.21%
Shares Change (QoQ) 466.31%
Owned by Institutions (%) 5.54%
Shares Floating 3.16M
Failed to Deliver (FTD) Shares 115
FTD / Avg. Volume 0.24%

Short Selling Information

The latest short interest is 65.09K, so 1.35% of the outstanding shares have been sold short.

Short Interest 65.09K
Short % of Shares Out 1.35%
Short % of Float 2.15%
Short Ratio (days to cover) 3.27

Valuation Ratios

The PE ratio is -0.31 and the forward PE ratio is -2.4. Senti Biosciences's PEG ratio is 0.01.

PE Ratio -0.31
Forward PE -2.4
PS Ratio 0
Forward PS 4.5
PB Ratio 0.63
P/FCF Ratio -0.39
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Senti Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.31.

Current Ratio 4.49
Quick Ratio 4.49
Debt / Equity 1.31
Debt / EBITDA -0.55
Debt / FCF -0.81
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.55M
Employee Count 34
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 4.99% in the last 52 weeks. The beta is 2.53, so Senti Biosciences's price volatility has been higher than the market average.

Beta 2.53
52-Week Price Change 4.99%
50-Day Moving Average 3.81
200-Day Moving Average 3.2
Relative Strength Index (RSI) 50.01
Average Volume (20 Days) 48.5K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -61.04M
Net Income -52.79M
EBITDA -61.04M
EBIT n/a
Earnings Per Share (EPS) -11.49
Full Income Statement

Balance Sheet

The company has 48.28M in cash and 33.54M in debt, giving a net cash position of 14.74M.

Cash & Cash Equivalents 48.28M
Total Debt 33.54M
Net Cash 14.74M
Retained Earnings -297.13M
Total Assets 97.84M
Working Capital 45.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -41.4M and capital expenditures -26K, giving a free cash flow of -41.42M.

Operating Cash Flow -41.4M
Capital Expenditures -26K
Free Cash Flow -41.42M
FCF Per Share -9.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SNTI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SNTI is $12, which is 235.2% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12
Price Target Difference 235.2%
Analyst Consensus Strong Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 18, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Jul 18, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -4.43
Piotroski F-Score 3